Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Feasibility and attractiveness of indication value-based pricing in key EU countries.
J Mark Access Health Policy. 2016 May 10;4. doi: 10.3402/jmahp.v4.30970. eCollection 2016.
J Mark Access Health Policy. 2016.
PMID: 27226845
Free PMC article.
Review.
Approaches to manage 'affordability' of high budget impact medicines in key EU countries.
Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin LA, Postma MJ, Touchot N.
Flume M, et al. Among authors: touchot n.
J Mark Access Health Policy. 2018 Jun 8;6(1):1478539. doi: 10.1080/20016689.2018.1478539. eCollection 2018.
J Mark Access Health Policy. 2018.
PMID: 29915664
Free PMC article.
Review.
Item in Clipboard
The payers' perspective on gene therapies.
Touchot N, Flume M.
Touchot N, et al.
Nat Biotechnol. 2015 Sep;33(9):902-4. doi: 10.1038/nbt.3332.
Nat Biotechnol. 2015.
PMID: 26348952
No abstract available.
Item in Clipboard
Early Insights from Commercialization of Gene Therapies in Europe.
Touchot N, Flume M.
Touchot N, et al.
Genes (Basel). 2017 Feb 17;8(2):78. doi: 10.3390/genes8020078.
Genes (Basel). 2017.
PMID: 28218692
Free PMC article.
Item in Clipboard
Cite
Cite